ZA200104163B - New cancer treatments. - Google Patents

New cancer treatments. Download PDF

Info

Publication number
ZA200104163B
ZA200104163B ZA200104163A ZA200104163A ZA200104163B ZA 200104163 B ZA200104163 B ZA 200104163B ZA 200104163 A ZA200104163 A ZA 200104163A ZA 200104163 A ZA200104163 A ZA 200104163A ZA 200104163 B ZA200104163 B ZA 200104163B
Authority
ZA
South Africa
Prior art keywords
cell lines
immunotherapeutic agent
derived
prostate cancer
treatment
Prior art date
Application number
ZA200104163A
Other languages
English (en)
Inventor
Angus George Dalgleish
Peter Michael Smith
Andrew Derek Sutton
Anthony Ian Walker
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Publication of ZA200104163B publication Critical patent/ZA200104163B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5152Tumor cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/884Vaccine for a specifically defined cancer prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
ZA200104163A 1998-12-10 2001-05-22 New cancer treatments. ZA200104163B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827103.4A GB9827103D0 (en) 1998-12-10 1998-12-10 New cancer treatments

Publications (1)

Publication Number Publication Date
ZA200104163B true ZA200104163B (en) 2002-02-04

Family

ID=10843925

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200104163A ZA200104163B (en) 1998-12-10 2001-05-22 New cancer treatments.

Country Status (19)

Country Link
US (1) US6699483B1 (no)
EP (1) EP1137434B1 (no)
JP (1) JP4607330B2 (no)
KR (1) KR100612552B1 (no)
AT (1) ATE412425T1 (no)
AU (1) AU777969B2 (no)
CA (1) CA2354046C (no)
CZ (1) CZ20012033A3 (no)
DE (1) DE69939837D1 (no)
ES (1) ES2315024T3 (no)
GB (1) GB9827103D0 (no)
HU (1) HUP0104857A3 (no)
IL (2) IL143295A0 (no)
MX (1) MXPA01005815A (no)
NO (1) NO326035B1 (no)
NZ (1) NZ512005A (no)
PL (1) PL348829A1 (no)
WO (1) WO2000033870A2 (no)
ZA (1) ZA200104163B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1272617B1 (en) * 2000-04-01 2011-04-27 Onyvax Limited Prostate cell lines and their use
MXPA03003638A (es) 2000-10-27 2004-01-26 Immuno Rx Inc Inmunoterapia con vacuna para pacientes inmunosuprimidos.
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
DE60326001D1 (de) * 2002-02-22 2009-03-12 Intracel Recources Llc Sterile immunogene nicht-tumorigene tumorzell-zusammensetzungen und verfahren
US7176022B2 (en) 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
US20050019336A1 (en) * 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
AU2004270113A1 (en) * 2003-08-26 2005-03-17 Becton, Dickinson And Company Methods for intradermal delivery of therapeutics agents
EP2591786B1 (en) 2003-10-16 2017-04-12 Cancure Limited Immunomodulating compositions and uses therefor
US8257715B1 (en) * 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
WO2006072625A2 (en) 2005-01-06 2006-07-13 Novo Nordisk A/S Anti-kir combination treatments and methods
US8802113B2 (en) * 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) * 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
GB0601598D0 (en) * 2006-01-26 2006-03-08 Stathopoulos Apostolos Method
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US20110250218A1 (en) * 2008-10-29 2011-10-13 Fong Lawrence H Disease-Associated Antigens and Methods of Use Thereof
DK2429585T3 (en) 2009-05-15 2018-07-30 Irx Therapeutics Inc VACCINE IMMUNOTHERAPY
AU2010328197B2 (en) 2009-12-08 2015-07-16 Irx Therapeutics, Inc. Method of reversing immune suppression of Langerhans cells
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
US20110150934A1 (en) * 2009-12-18 2011-06-23 University Of Notre Dame Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
CN105850982B (zh) * 2016-04-29 2018-08-17 绍兴市人民医院 一种新型组织冻存液
CN105850981B (zh) * 2016-04-29 2018-07-20 绍兴市人民医院 冻存肿瘤组织的方法
US20220282220A1 (en) * 2019-07-24 2022-09-08 Sl Bigen Inc. Method for preparation of immortalized stem cell line and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
AU1355697A (en) 1995-12-28 1997-07-28 Johns Hopkins University School Of Medicine, The Allogeneic paracrine cytokine tumor vaccines
DE69721731T2 (de) * 1996-02-02 2004-03-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immortalisierte menschliche prostata-epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs
AU767842B2 (en) * 1998-11-03 2003-11-27 Cell Genesys, Inc. Cancer-associated antigens and methods of their identification
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments

Also Published As

Publication number Publication date
IL143295A0 (en) 2002-04-21
CA2354046A1 (en) 2000-06-15
NO20012818L (no) 2001-06-07
US6699483B1 (en) 2004-03-02
KR20010090873A (ko) 2001-10-19
JP2002531521A (ja) 2002-09-24
HUP0104857A3 (en) 2004-04-28
AU777969B2 (en) 2004-11-04
WO2000033870A3 (en) 2000-08-17
WO2000033870A2 (en) 2000-06-15
NO326035B1 (no) 2008-09-01
GB9827103D0 (en) 1999-02-03
DE69939837D1 (de) 2008-12-11
EP1137434A2 (en) 2001-10-04
PL348829A1 (en) 2002-06-17
KR100612552B1 (ko) 2006-08-11
NO20012818D0 (no) 2001-06-07
IL143295A (en) 2006-04-10
CZ20012033A3 (cs) 2001-10-17
JP4607330B2 (ja) 2011-01-05
MXPA01005815A (es) 2003-04-02
NZ512005A (en) 2004-01-30
ATE412425T1 (de) 2008-11-15
CA2354046C (en) 2011-02-15
HUP0104857A2 (hu) 2002-04-29
ES2315024T3 (es) 2009-03-16
EP1137434B1 (en) 2008-10-29
AU1668700A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
CA2354046C (en) New cancer treatments
US8034360B2 (en) Use of human prostate cell lines in cancer treatment
AU2002365291A1 (en) Pharmaceutical composition for inducing an immune response in a human or animal
US8545835B2 (en) Human prostate cell lines in cancer treatment
WO2000033871A2 (en) Use of human prostate tumour cell lines in cancer treatment
NZ527763A (en) Allogeneic immunotherapeutic agent comprising three human prostate tumour cell lines derived from three different primary tumours useful in treating prostate cancer